Skip to main content
. 2021 Mar 18;9(3):343–353. doi: 10.1177/2050640620951403

FIGURE 2.

FIGURE 2

Adjusted odds ratios (ORs) for the association of proton pump inhibitor (PPI) use and the diagnosis of pathologically confirmed gastric intestinal metaplasia (GIM) among the whole cohort, Helicobacter pylori‐negative patients, patients treated for H. pylori infection, and patients with verified H. pylori eradication after treatment (a sensitivity analysis)